- The trend backdrop is active with a 7-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
SHREEPUSHK
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Shree Pushkar Chemicals & Fertilisers Limited · Basic Materials · Specialty Chemicals
Latest close
407.1 INR
2.6%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 13.0% above the Trend Line and sits at 66.2% of its 52-week range. The latest completed week returned 2.6%, after a -4.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 46/100. Near-term considerations: volume confirmation is below normal.
Setup score
50
out of 100
Latest Close
407.1 INR
7 Aug 2026
1W Return
2.6%
latest completed week
4W Return
-4.6%
short-term follow-through
12W Return
4.2%
quarterly tape
Trend Breadth
53.8%
28 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- 2 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
2.6%
Latest completed week; four-week move -4.6%.
Indicator stack
54/53
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
46/100
21 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 13.0% above the Trend Line and sits at 66.2% of its 52-week range. The latest completed week returned 2.6%, after a -4.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.7512-week average 0.58
12-week confirmation
Trend active7/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.75Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -4.6% over four weeks, 4.2% over 12 weeks, and 11.2% over one year. The current trend has remained active for 7 consecutive weeks.
Performance by holding period
Active trend streak7 weeks
Active weeks in one year28
Trend breadth53.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.42Latest activity-pressure read.
Pressure change-55.8%Four-week change in activity pressure.
Leadership10.84Latest relative-leadership reading.
RS change-42.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 94%
Model confidence 88%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength89/100Blend of value, momentum, and quality. Underlying universe rank 12; rank 1 is best.
Value76/100Relative valuation strength. Underlying universe rank 25; rank 1 is best.
Quality62/100Profitability and accounting quality. Underlying universe rank 39; rank 1 is best.
Momentum76/100Medium-term price momentum. Underlying universe rank 25; rank 1 is best.
Growth76/100Revenue and earnings growth. Underlying universe rank 25; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework51/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 18.8x Price divided by trailing earnings.
- Price / sales
- 1.3x Market value relative to trailing revenue.
- EV / EBITDA
- 12.8x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -1.0% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 33.9% Gross profit retained from each unit of revenue.
- Operating margin
- 7.8% Operating profit retained from revenue.
- Free-cash-flow margin
- -1.5% Free cash flow generated from revenue.
- Return on invested capital
- 7.7% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 21.1% Latest one-year revenue growth.
- EPS growth
- 19.6% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 7/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.5% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.5% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 1.2x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment46/100
Weighted news tone is neutral across 21 relevant articles.
6 positive · 10 neutral · 5 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-14.5%Distance below the 52-week high.
13-week volatility5.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher16 of 2610 weeks finished lower.
Best week+12.9%Week of 24 Apr.
Worst week-11.2%Week of 22 May.
Latest week+2.6%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains9
Flat weeks0
Modest losses3
Sharp losses7
Recent vol5.5%13-week weekly-return volatility.
Base vol5.9%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew5.1% / -4.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Basic Materials
4-week rank- / 100
Group average2.8%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD52.0%positive activity pressure
RS63.0%positive relative leadership
Four-week leaders
IndustryIN Specialty Chemicals
4-week rank87 / 100
Group average5.8%
Trend breadth77.0%
Trend77.0%active weekly trend signals
MD75.0%positive activity pressure
RS72.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape52/100
Trend, activity pressure, participation, and risk combine to a 52/100 tape read.
Indicator analysis73/100Latest 12-week confirmation: trend 7/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.75; 2 reversal markers Factors75/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 56; Small Cap Core rank 27 SVQF51/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 779.5 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment46/100Weighted news tone is neutral across 21 relevant articles.
Neogen Chemicals Publishes Q1 FY27 Earnings Presentation Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 407.1 INR | 2.6% | 360.2 INR | 286.5 INR | 0.42 | 10.84 | 162.4K | On |
| 31 Jul 2026 | 396.8 INR | 2.6% | 357.9 INR | 285.0 INR | 0.65 | 9.07 | 111.5K | On |
| 24 Jul 2026 | 386.9 INR | -5.2% | 357.3 INR | 283.7 INR | 0.82 | 9.21 | 157.6K | On |
| 17 Jul 2026 | 407.9 INR | -4.5% | 357.1 INR | 282.4 INR | 0.95 | 12.70 | 296.8K | On |
| 10 Jul 2026 | 427.0 INR | 5.7% | 356.1 INR | 280.9 INR | 0.95 | 18.93 | 549.8K | On |
| 3 Jul 2026 | 404.1 INR | 0.2% | 354.7 INR | 279.4 INR | 0.74 | 12.81 | 43.9K | On |
| 26 Jun 2026 | 403.1 INR | 1.8% | 354.4 INR | 278.0 INR | 0.61 | 14.04 | 0 | On |
| 19 Jun 2026 | 396.0 INR | 10.7% | 354.3 INR | 276.6 INR | 0.51 | 12.80 | 32.3K | Off |
| 12 Jun 2026 | 357.6 INR | -0.5% | 354.8 INR | 275.2 INR | 0.39 | 4.16 | 10.6K | Off |
| 5 Jun 2026 | 359.4 INR | -1.5% | 356.6 INR | 274.1 INR | 0.51 | 6.13 | 49.9K | Off |
| 29 May 2026 | 365.0 INR | 5.2% | 357.8 INR | 273.0 INR | 0.67 | 7.28 | 281.3K | Off |
| 22 May 2026 | 346.8 INR | -11.2% | 358.9 INR | 271.9 INR | 0.80 | 1.65 | 652.6K | Off |
| 15 May 2026 | 390.7 INR | -5.1% | 361.2 INR | 270.9 INR | 1.09 | 15.28 | 815.7K | Off |
| 8 May 2026 | 411.8 INR | 4.3% | 361.5 INR | 269.5 INR | 0.96 | 19.59 | 564.8K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.